Astellas Pharma Inc. - Total Stockholder Equity

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Total-Stockholder-Equity" stands at 1.48 Trillion Japanese Yens as of 06/30/2025, the lowest value since 06/30/2022.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Total Stockholder Equity" stands at 1.48 Trillion JPY. This represents a decrease of -2.08 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -11.61 percent compared to the value the year prior.
The 1 year change in percent is -11.61.
The 3 year change in percent is -3.72.
The 5 year change in percent is 13.40.
The 10 year change in percent is 11.10.

The Serie's long term average value is 1.30 Trillion Japanese Yens. It's latest available value, on 06/30/2025, is 13.68 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 06/30/2025, is +51.18%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is -11.61%.